DKGlow was born from a simple question: why aren’t the most promising ingredients in research showing up in the products on shelves?
At DKGlow, we are driven by a mission to transform skincare and wellness through the power of science and nature. Founded by Dr. Dorra Frikha-Benayed — a scientist with a PhD in Biomedical Engineering from City College of New York — DKGlow is rooted in groundbreaking research in cellular and molecular bioengineering.
Dr. Benayed's work focuses on how cellular processes — particularly energy production and oxidative stress — shape health, aging, and regeneration. Her expertise in mitochondrial bioenergetics and redox biology revealed the body's remarkable ability to repair and regenerate itself when mitochondrial function is optimised.
That passion for unlocking the body's natural renewal potential is what created DKGlow. Where conventional products provide only short-term cosmetic effects, our offerings harness the regenerative power of Methylene Blue — a scientifically validated compound for cellular vitality and renewal — paired with clinical infrared wavelengths.
Dr. Dorra Frikha-Benayed
Founder & Formulator, DKGlow · Biomedical Engineering, CCNY
IBTimes · March 2026
“The mitochondria is the powerhouse of the cell. We're just here to make sure it keeps powering.”
Three publications that reflect the scientific foundation DKGlow is built on. Dr. Frikha-Benayed's research focuses on mitochondrial biology and cellular bioenergetics — the same systems that underlie skin renewal.
Poudel SB, Frikha-Benayed D, Ruff RR, et al.
Investigation of methylene blue and mitoquinone as mitochondrial-targeting interventions for age-related skeletal decline. In vitro effects observed; in vivo bone-loss outcomes did not change in the model used.
Read paperLewis KJ, Frikha-Benayed D, Louie J, et al.
Demonstrated how individual osteocytes encode the magnitude and frequency of mechanical loading through calcium signalling — a foundational result for cellular mechanobiology.
Read paperFrikha-Benayed D, Basta-Plajkic J, Majeska RJ, Schaffler MB
First-author work showing that osteocytes in different regions of cortical bone carry distinct oxidative-metabolism and mitochondrial-activity profiles — relevant to how local bioenergetics shape tissue function.
Read paperSelected from Dr. Frikha-Benayed's body of work in bone biology and mitochondrial bioenergetics. Full list and citation counts on Google Scholar .
Mitochondrial function is compromised in cortical bone osteocytes of long-lived growth-hormone-receptor null mice
Liu Z, Solesio ME, Schaffler MB, Frikha-Benayed D, et al.
Osteocyte oxidative stress following estrogen loss, microdamage and disuse
Frikha-Benayed D, Schaffler M, Basta-Plajkic J, Majeska RJ
A potential role for the NLRP3 inflammasome in osteocyte-mediated triggering of osteoclast differentiation
Frikha-Benayed D, Lapshina M, Majeska R, Schaffler M
Method of treating or preventing osteoporosis (App. 15/618,783)
Frikha-Benayed D, Schaffler MB
Acute increase in osteocyte oxidative stress at focal microdamage site in bone
Frikha-Benayed D, Basta-Plajkic J, Majeska RJ, Schaffler MB
Osteocyte apoptosis caused by hindlimb unloading is required to trigger osteocyte RANKL production and subsequent resorption of cortical and trabecular bone
Cabahug-Zuckerman P, Frikha-Benayed D, Majeska RJ, et al.
In vivo assessment of osteocyte oxidative metabolism
Frikha-Benayed D
Estrogen loss causes mitochondrial stress in osteocytes in vivo
Frikha-Benayed D, Basta-Plajkic J, Majeska RJ, Schaffler M
Osteocytes reveal NADH fluorescence heterogeneity in situ in response to ischemia
Frikha-Benayed D, Basta-Plajkic J, Majeska R, Schaffler M
Both Methylene Blue and infrared therapy target the same root cause of skin aging: declining mitochondrial function.
A mitochondria-targeting antioxidant that crosses the skin barrier and donates electrons directly to the electron transport chain — boosting cellular energy, neutralizing free radicals, and promoting collagen synthesis.
Peer-reviewed in Scientific Reports (Xiong et al., 2021): MB reduced oxidative damage and extended cellular lifespan in human dermal fibroblasts.
Red (650–670 nm) and near-infrared (850–880 nm) wavelengths penetrate 5–10 mm into tissue, studied for their interaction with cytochrome c oxidase in the mitochondrial electron transport chain — the mechanism most often cited in the ATP-production and tissue-renewal literature.
Reviewed across 50+ trials (Hamblin MR, 2016, Photobiomodulation): studied effects on skin renewal and tissue recovery.
Every formulation is rooted in peer-reviewed research on mitochondrial function and cellular health.
No harsh synthetics. Every ingredient is chosen for efficacy and environmental responsibility.
Dr. Dorra Frikha-Benayed brings years of biomedical research directly into every product.
Clinical-grade science shouldn't cost a fortune. Free shipping on orders $75+.
Browse our full line of Methylene Blue and Infrared products.